Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Spallone

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cell Cycle (Georgetown, Tex.)|March 1, 2012
TRIM8 and p53: making the right decisionElisabetta Botti, Giulia Spallone, Antonio Costanzo
Cancers|November 12, 2013
Targeted therapy in nonmelanoma skin cancersGiulia Spallone, Elisabetta Botti, Antonio Costanzo
Expert Opinion on Drug Safety|January 11, 2011
EfalizumabMarina Talamonti, Giulia Spallone, Alessandro Di Stefani, et al.
The International Journal of Developmental Biology|September 17, 2015
Programmed cell death in the skinAntonio Costanzo, Francesca Fausti, Giulia Spallone, et al.
Current Pharmaceutical Biotechnology|January 19, 2012
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic targetElisabetta Botti, Giulia Spallone, Roberta Caruso, et al.
Cell Death Discovery|March 11, 2017
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146Maria Cristina Rapanotti, Elena Campione, Giulia Spallone, et al.
Italian Journal of Dermatology and Venereology|October 21, 2020
Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with IpilimumabGiulia Spallone, Alessandra Ventura, Mauro Mazzeo, et al.
Dermatology (Basel, Switzerland)|October 31, 2008
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapyAntonio Costanzo, Marina Talamonti, Giulia Spallone, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 12, 2018
Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapyGiulia Spallone, Virginia Garofalo, Eliseo Picchi, et al.
Italian Journal of Dermatology and Venereology|May 28, 2021
Coronavirus 2019 disease and skin cancer: a single center experienceCosimo DI Raimondo, Giulia Spallone, Dionisio Silvaggio, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cell Cycle (Georgetown, Tex.)|March 1, 2012
TRIM8 and p53: making the right decisionElisabetta Botti, Giulia Spallone, Antonio Costanzo
Cancers|November 12, 2013
Targeted therapy in nonmelanoma skin cancersGiulia Spallone, Elisabetta Botti, Antonio Costanzo
Expert Opinion on Drug Safety|January 11, 2011
EfalizumabMarina Talamonti, Giulia Spallone, Alessandro Di Stefani, et al.
The International Journal of Developmental Biology|September 17, 2015
Programmed cell death in the skinAntonio Costanzo, Francesca Fausti, Giulia Spallone, et al.
Current Pharmaceutical Biotechnology|January 19, 2012
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic targetElisabetta Botti, Giulia Spallone, Roberta Caruso, et al.
Cell Death Discovery|March 11, 2017
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146Maria Cristina Rapanotti, Elena Campione, Giulia Spallone, et al.
Italian Journal of Dermatology and Venereology|October 21, 2020
Cancer duplicity: a case of chronic lymphocytic leukemia and metastatic melanoma treated with IpilimumabGiulia Spallone, Alessandra Ventura, Mauro Mazzeo, et al.
Dermatology (Basel, Switzerland)|October 31, 2008
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapyAntonio Costanzo, Marina Talamonti, Giulia Spallone, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 12, 2018
Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapyGiulia Spallone, Virginia Garofalo, Eliseo Picchi, et al.
Italian Journal of Dermatology and Venereology|May 28, 2021
Coronavirus 2019 disease and skin cancer: a single center experienceCosimo DI Raimondo, Giulia Spallone, Dionisio Silvaggio, et al.
Pageof 3